Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges - PubMed

Clinical Trial

Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges

W Al-Nakib et al. J Antimicrob Chemother. 1987 Dec.

Abstract

Following a tolerance study, double-blind placebo controlled trials were conducted to determine the prophylactic effect of zinc gluconate lozenges on rhinovirus challenge and, in a third study, their therapeutic efficacy when given at the start of colds caused by virus inoculation was tested. In the prophylaxis study a total of 57 volunteers received lozenges of either zinc gluconate (23 mg) (29 volunteers) or matched placebo (28 volunteers) every 2 h while awake during a period of four and a half days. They were challenged with 10(2) tissue culture infecting dose (TCID50) of human rhinovirus 2 (HRV-2) on the second day of medication, and were monitored daily for symptoms and signs of colds and laboratory evidence of infection. Zinc reduced the total mean clinical score from 8.2 in the placebo group to 5.7 and the reduction of the mean clinical score was statistically significant on the second day after virus challenge. In the therapeutic study 69 volunteers were inoculated with 10(2) TCID50 of HRV-2 and those who developed cold symptoms were randomly allocated to receive either zinc gluconate lozenges (six volunteers) or matched placebo lozenges (six volunteers) every two hours they were awake for six days. Treatment of colds with zinc reduced the mean daily clinical score and this was statistically significant on the fourth and fifth day of medication. Similarly, medication also reduced the mean daily nasal secretion weight and total tissue count and these reductions were statistically significant on days two and six for nasal secretion weights and days four to six of medication for tissue counts when compared with placebo.(ABSTRACT TRUNCATED AT 250 WORDS)

Comment in

• Cold-Eeze lozenge for common colds.

  Eby G. Eby G. Am J Ther. 2003 May-Jun;10(3):233; author reply 233-4. doi: 10.1097/00045391-200305000-00012. Am J Ther. 2003. PMID: 12756432 No abstract available.

Similar articles

• Zinc lozenges reduce the duration of common cold symptoms.

  [No authors listed] [No authors listed] Nutr Rev. 1997 Mar;55(3):82-5. doi: 10.1111/j.1753-4887.1997.tb01601.x. Nutr Rev. 1997. PMID: 9170894 Free PMC article. Review.

• Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.

  Farr BM, Conner EM, Betts RF, Oleske J, Minnefor A, Gwaltney JM Jr. Farr BM, et al. Antimicrob Agents Chemother. 1987 Aug;31(8):1183-7. doi: 10.1128/AAC.31.8.1183. Antimicrob Agents Chemother. 1987. PMID: 2820298 Free PMC article. Clinical Trial.

• Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.

  Mossad SB, Macknin ML, Medendorp SV, Mason P. Mossad SB, et al. Ann Intern Med. 1996 Jul 15;125(2):81-8. doi: 10.7326/0003-4819-125-2-199607150-00001. Ann Intern Med. 1996. PMID: 8678384 Clinical Trial.

• The role of zinc lozenges in treatment of the common cold.

  Garland ML, Hagmeyer KO. Garland ML, et al. Ann Pharmacother. 1998 Jan;32(1):63-9. doi: 10.1345/aph.17128. Ann Pharmacother. 1998. PMID: 9475824 Review.

Cited by

• Zinc lozenges reduce the duration of common cold symptoms.

  [No authors listed] [No authors listed] Nutr Rev. 1997 Mar;55(3):82-5. doi: 10.1111/j.1753-4887.1997.tb01601.x. Nutr Rev. 1997. PMID: 9170894 Free PMC article. Review.

• Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects.

  Petrus EJ, Lawson KA, Bucci LR, Blum K. Petrus EJ, et al. Curr Ther Res Clin Exp. 1998 Sep;59(9):595-607. doi: 10.1016/S0011-393X(98)85058-3. Epub 2001 Oct 10. Curr Ther Res Clin Exp. 1998. PMID: 32287355 Free PMC article.

• Protection against membrane-mediated cytotoxicity by calcium and zinc.

  Mahadevan D, Ndirika A, Vincent J, Bashford L, Chambers T, Pasternak C. Mahadevan D, et al. Am J Pathol. 1990 Mar;136(3):513-20. Am J Pathol. 1990. PMID: 2156428 Free PMC article.

• Zinc in Human Health and Infectious Diseases.

  Maywald M, Rink L. Maywald M, et al. Biomolecules. 2022 Nov 24;12(12):1748. doi: 10.3390/biom12121748. Biomolecules. 2022. PMID: 36551176 Free PMC article. Review.

• Zinc lozenges may shorten the duration of colds: a systematic review.

  Hemilä H. Hemilä H. Open Respir Med J. 2011;5:51-8. doi: 10.2174/1874306401105010051. Epub 2011 Jun 23. Open Respir Med J. 2011. PMID: 21769305 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information